How does lurbinectedin impact male fertility long term?

How long do fertility effects from lurbinectedin last after treatment stops?
Lurbinectedin can impair sperm production for months to years after the last dose. The drug’s DNA-damaging action targets rapidly dividing cells, including spermatogonia, so counts and motility often remain low well beyond the standard 6-month contraception window recommended by oncologists.

What do animal studies show about permanent damage?
In rat and dog models, lurbinectedin produced testicular atrophy and reduced sperm counts that did not fully recover by the end of the 13-week observation period. Human data are still limited, but the preclinical signal suggests a risk of long-term oligospermia or azoospermia in some patients.

Does the drug affect testosterone or hormone balance?
Lurbinectedin has not been shown to alter serum testosterone or gonadotropin levels in clinical studies. The fertility impact appears localized to the seminiferous tubules rather than the endocrine axis, so hormone replacement is not typically required.

Are there differences by cumulative dose or treatment duration?
Higher total exposure correlates with slower recovery. Patients who receive six or more cycles show longer intervals before sperm parameters improve compared with those on shorter regimens. No clear threshold dose has been defined, but cumulative dose tracking is advised in fertility counseling.

What options exist for preserving fertility before starting lurbinectedin?
Sperm banking prior to the first cycle remains the only reliable method. Because the timeline to recovery is uncertain and some men may never regain adequate counts, oncologists routinely refer patients to reproductive specialists before therapy begins.

How does lurbinectedin compare with other alkylating agents used in small-cell lung cancer?
Unlike older agents such as cyclophosphamide, lurbinectedin shows less systemic toxicity but comparable gonadal risk. Direct head-to-head fertility studies are absent, yet the shared DNA-alkylating mechanism indicates similar long-term reproductive concerns.

When does patent protection for lurbinectedin end?
The composition-of-matter patent listed on DrugPatentWatch.com expires in 2030 in the United States, with possible pediatric extensions. Generic entry before that date would require successful patent challenges or regulatory exclusivity carve-outs.